Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,
RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023
Investment is additive to KKR’s existing health care growth strategy
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
Subscribe To Our Newsletter & Stay Updated
